PureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting ...

TUS+VEN+AZA Triplet Frontline Therapy in Newly Diagnosed AML Patients Now Enrolling at U.S. SitesTUS and TUS+VEN Broadly Active Across AML ...

A recent international anti-drug operation suggested supercharged international operations may be more common in the future.

“These poster presentations ... and the treatment of drug-resistant epilepsy with VNS Therapy™. Actual events may differ materially from those indicated in our forward-looking statements as a result ...

The most recent FDA approval belongs to BCG plus N-803, which has an initial complete response of 62%, falling to just 36% at 12 months. For technologies currently under clinical evaluation, ...

Reaffirms New Drug Application (NDA) first quarter 2025 submission guidanceConfirms no additional adult clinical trials are necessary prior to ...

Dosage for Vyvanse (lisdexamfetamine) may vary based on your individual treatment plan. The typical starting dosage for ADHD and binge eating disorder is 30 milligrams (mg) per day. Your doctor ...

The presentation will illustrate how Aptevo leverages its proprietary platforms to rapidly ... reducing risk and increasing the likelihood of clinical success for future drug candidates. Aptevo has ...

Lexapro comes as a tablet that you swallow. The drug also used to be available as a liquid solution that you swallow, but this form of Lexapro has been discontinued. The information that follows ...

Acetaminophen comes in several dosage forms. The dosage can vary depending on what condition the drug is used to help treat. Acetaminophen is a generic over-the-counter (OTC) drug that can be used ...